Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Clinical implementation and current advancement of blood liquid biopsy in cancer.
Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer.
Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical implementation and current advancement of blood liquid biopsy in cancer.
Clinical implementation and current advancement of blood liquid biopsy in cancer. J Hum Genet. 2021 Sep; 66(9):909-926.
View in:
PubMed
subject areas
Biomarkers, Tumor
Circulating Tumor DNA
Humans
Liquid Biopsy
Neoplasms
authors with profiles
Yusuke Nakamura